Nomura Asset Management CO LTD Kiniksa Pharmaceuticals, Ltd. Transaction History

Nomura Asset Management CO LTD

16 transactions

Quarter	Operation	Price Per share
Q1 2024 May 13, 2024	BUY	$17.63 - $21.74 $0 - $0
Q4 2023 Feb 09, 2024	BUY	$14.37 - $19.07 $0 - $0
Q3 2023 Nov 03, 2023	BUY	$13.62 - $20.2 $0 - $0
Q2 2023 Aug 14, 2023	BUY	$10.44 - $16.48 $0 - $0
Q1 2023 May 11, 2023	BUY	$10.7 - $15.79 $0 - $0
Q4 2022 Feb 14, 2023	BUY	$11.42 - $17.05 $0 - $0
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $0 - $0
Q3 2022 Nov 10, 2022	BUY	$9.76 - $13.41 $0 - $0
Q3 2022 Nov 10, 2022	BUY	$9.76 - $13.41 $0 - $0
Q2 2022 Aug 12, 2022	BUY	$7.6 - $11.41 $0 - $0
Q1 2022 May 13, 2022	BUY	$9.3 - $12.37 $0 - $0
Q4 2021 Feb 01, 2022	BUY	$10.39 - $15.15 $0 - $0
Q3 2021 Nov 12, 2021	BUY	$11.39 - $16.23 $0 - $0
Q2 2021 Aug 06, 2021	BUY	$13.22 - $19.09 $0 - $0
Q1 2021 May 14, 2021	BUY	$16.68 - $23.97 $0 - $0
Q4 2020 Feb 12, 2021	BUY	$14.8 - $21.15 $0 - $0

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $760M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.